StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Zivo Bioscience's operating cash flow for the twelve months ending Sep 30, 2025 was -$3.08M. For fiscal 2024 it was -$4.31M. The highest annual figure on record is -$1.29M in fiscal 2011.

Annual operating cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$4.31M–
FY2023Dec 31, 2023-$5.80M–
FY2022Dec 31, 2022-$7.10M–
FY2021Dec 31, 2021-$6.80M–
FY2020Dec 31, 2020-$2.59M–
FY2019Dec 31, 2019-$3.71M–
FY2018Dec 31, 2018-$5.01M–
FY2017Dec 31, 2017-$4.24M–
FY2016Dec 31, 2016-$2.54M–
FY2015Dec 31, 2015-$2.30M–
FY2014Dec 31, 2014-$2.74M–
FY2013Dec 31, 2013-$2.99M–
FY2012Dec 31, 2012-$1.77M–
FY2011Dec 31, 2011-$1.29M–
FY2010Dec 31, 2010-$1.44M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025-$266.56K–
Q2 FY2025Jun 30, 2025-$476.41K–
Q1 FY2025Mar 31, 2025-$1.43M–
Q4 FY2024Dec 31, 2024-$905.72K–
Q3 FY2024Sep 30, 2024-$1.09M–
Q2 FY2024Jun 30, 2024-$623.65K–
Q1 FY2024Mar 31, 2024-$1.70M–
Q4 FY2023Dec 31, 2023-$715.73K–
Q3 FY2023Sep 30, 2023-$1.97M–
Q2 FY2023Jun 30, 2023-$985.67K–
Q1 FY2023Mar 31, 2023-$2.13M–
Q4 FY2022Dec 31, 2022-$1.45M–
Q3 FY2022Sep 30, 2022-$1.49M–
Q2 FY2022Jun 30, 2022-$1.31M–
Q1 FY2022Mar 31, 2022-$2.86M–
Q4 FY2021Dec 31, 2021-$1.90M–
Q3 FY2021Sep 30, 2021-$1.80M–
Q2 FY2021Jun 30, 2021-$2.05M–
Q1 FY2021Mar 31, 2021-$1.05M–
Q4 FY2020Dec 31, 2020-$901.48K–
Q3 FY2020Sep 30, 2020-$564.12K–
Q2 FY2020Jun 30, 2020-$339.75K–
Q1 FY2020Mar 31, 2020-$783.07K–
Q4 FY2019Dec 31, 2019-$651.33K–
Q3 FY2019Sep 30, 2019-$1.33M–
Q2 FY2019Jun 30, 2019-$1.15M–
Q1 FY2019Mar 31, 2019-$576.23K–
Q4 FY2018Dec 31, 2018-$1.12M–
Q3 FY2018Sep 30, 2018-$1.23M–
Q2 FY2018Jun 30, 2018-$1.78M–
Q1 FY2018Mar 31, 2018-$874.00K–
Q4 FY2017Dec 31, 2017-$1.36M–
Q3 FY2017Sep 30, 2017-$1.23M–
Q2 FY2017Jun 30, 2017-$1.12M–
Q1 FY2017Mar 31, 2017-$529.49K–
Q4 FY2016Dec 31, 2016-$819.85K–
Q3 FY2016Sep 30, 2016-$440.45K–
Q2 FY2016Jun 30, 2016-$525.00K–
Q1 FY2016Mar 31, 2016-$758.18K–
Q4 FY2015Dec 31, 2015-$486.53K–

More Zivo Bioscience figures

See a number that looks wrong?